UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 25

Sortiert nach

Antineoplastic drug occupational exposure: a new integrated approach to evaluate exposure and early genotoxic and cytotoxic effects by no-invasive Buccal Micronucleus Cytome Assay biomarker

Toxicology letters, 2019-11, Vol.316, p.20-26

2019

Volltextzugriff (PDF)

4CPS-390 Dispensing of anticancer investigational drugs during lockdown for the SARS-CoV-2 pandemic: experience in an oncological centre

European journal of hospital pharmacy. Science and practice, 2021-03, Vol.28 (Suppl 1), p.A108-A108

2021

Volltextzugriff (PDF)

95P Italian national policy to access molecular tumor boards: Opportunity or restraint for precision oncology?

ESMO open, 2024-02, Vol.9, p.102321, Article 102321

2024

Volltextzugriff (PDF)

4CPS-193 Measuring the impact of hospital pharmacist prescription reviewing in an oncology setting on the pharmacovigilance reporting in a comprehensive cancer centre

European journal of hospital pharmacy. Science and practice, 2020-03, Vol.27 (Suppl 1), p.A139-A139

2020

Volltextzugriff (PDF)

4CPS-194 The underreporting rate as a pharmacovigilance process indicator in a comprehensive cancer centre

European journal of hospital pharmacy. Science and practice, 2020-03, Vol.27 (Suppl 1), p.A139-A139

2020

Volltextzugriff (PDF)

4CPS-233 Coverage of energy and protein needs in patients with kidney failure or liver failure receiving total parenteral nutrition

European journal of hospital pharmacy. Science and practice, 2018-03, Vol.25 (Suppl 1), p.A149-A150

2018

Volltextzugriff (PDF)

3PC-044 In use physicochemical stability of pembrolizumab under the dilution condition required for use in a day hospital

European journal of hospital pharmacy. Science and practice, 2020-03, Vol.27 (Suppl 1), p.A42-A42

2020

Volltextzugriff (PDF)

5PSQ-049 Palbociclib in metastatic breast cancer treatment: real life toxicity and frequency of dose reduction or permanent discontinuation

European journal of hospital pharmacy. Science and practice, 2020-03, Vol.27 (Suppl 1), p.A172-A172

2020

Volltextzugriff (PDF)

GM-021 Zoledronic acid versus denosumab: a budget impact analysis

European journal of hospital pharmacy. Science and practice, 2017-03, Vol.24 (Suppl 1), p.A167-A167

2017

Volltextzugriff (PDF)

CP-082 Impact of pharmacists’ expertise on personalised parenteral nutrition prescriptions in an intensive care unit: physicians’ perceptions

European journal of hospital pharmacy. Science and practice, 2017-03, Vol.24 (Suppl 1), p.A36-A37

2017

Volltextzugriff (PDF)

5PSQ-117 Failure mode and effects criticality analysis: multicentric application on cancer chemotherapy process

European journal of hospital pharmacy. Science and practice, 2018-03, Vol.25 (Suppl 1), p.A218-A219

2018

Volltextzugriff (PDF)

4CPS-231 The use of cannabis oil in oncological pain: analysis of the outcomes in real practice at a cancer centre

European journal of hospital pharmacy. Science and practice, 2018-03, Vol.25 (Suppl 1), p.A149-A149

2018

Volltextzugriff (PDF)

GM-019 Analysis of the categories of clinical trials in an oncological institute: glimpse into the future

European journal of hospital pharmacy. Science and practice, 2017-03, Vol.24 (Suppl 1), p.A166-A166

2017

Volltextzugriff (PDF)

Thalidomide in patients with advanced hepatocellular carcinoma: A clinical/biological study

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.15076-15076

2007

Volltextzugriff (PDF)

Tie2 Expressing Monocytes in the Spleen of Patients with Primary Myelofibrosis

PloS one, 2016-06, Vol.11 (6), p.e0156990-e0156990

2016

Volltextzugriff (PDF)

Tumor cell proliferation in early gastric cancer: biological and clinical behavior

Hepato-gastroenterology, 2004-01, Vol.51 (55), p.264

2004

Volltextzugriff (PDF)

The role of surgery in the multimodal treatment of primary gastric non‐Hodgkin's lymphomas a report of 76 cases and review of the literature

Cancer, 1990-06, Vol.65 (11), p.2528-2536

1990

Volltextzugriff (PDF)

Catheter seeding of hepatocellular carcinoma following placement of a total implantable access port system

Hepato-gastroenterology, 1998-01, Vol.45 (19), p.206

1998

Volltextzugriff (PDF)

Correlation of cell proliferation and clinical behaviour of early gastric cancer. Immunohistochemical study with "in vivo" bromodeoxyuridine labelling

European journal of histochemistry, 1997, Vol.41 Suppl 2, p.127

1997

Volltextzugriff (PDF)

Protein-sparing therapy after major abdominal surgery : Lack of clinical effects

Annals of surgery, 1996-04, Vol.223 (4), p.357-362

1996

Volltextzugriff (PDF)

Depression among general hospital patients in Greece

Acta psychiatrica Scandinavica, 1989-02, Vol.79 (2), p.148-152

1989

Volltextzugriff (PDF)

Pre-operative nutritional support and tumour cell kinetics in malnourished patients with gastric cancer

Clinical nutrition (Edinburgh, Scotland), 1991, Vol.10, p.77-84

1991

Volltextzugriff (PDF)

FEC vs high dose fec in the treatment of advanced breast cancer

European journal of cancer (1990), 1994, Vol.30, p.S18-S18

1994

Volltextzugriff (PDF)

The role of surgery in the multimodal treatment of primary gastric non-hodgkin's lymphomas

Cancer, 1990, Vol.65 (11), p.2528-2536

1990

Volltextzugriff (PDF)

P.21 Modifications of immunological parameters during pre and postoperative tpn with and without fat emulsions in gastric cancer patients

Clinical nutrition (Edinburgh, Scotland), 1983, Vol.2, p.67-67

1983

Volltextzugriff (PDF)

1 – 25 von 25

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(25)

Sprache

Englisch
(25)

Erscheinungsjahr

n.n

Thema

Science & Technology
(8)
Life Sciences & Biomedicine
(7)
Humans
(6)
Male
(6)
Middle Aged
(6)
Biological And Medical Sciences
(5)
Female
(5)
Medical Sciences
(5)
Aged
(4)
Surgery
(3)
Adolescent
(2)
Adult
(2)
Breast Cancer
(2)
Cell Division
(2)
Clinical Trials
(2)
Gastroenterology & Hepatology
(2)
Gastroenterology. Liver. Pancreas. Abdomen
(2)
Immunotherapy
(2)
Metastasis
(2)
Monoclonal Antibodies
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Antineoplastic drug occupational exposure: a new integrated approach to evaluate exposure and early genotoxic and cytotoxic effects by no-invasive Buccal Micronucleus Cytome Assay biomarker

4CPS-390 Dispensing of anticancer investigational drugs during lockdown for the SARS-CoV-2 pandemic: experience in an oncological centre

95P Italian national policy to access molecular tumor boards: Opportunity or restraint for precision oncology?

4CPS-193 Measuring the impact of hospital pharmacist prescription reviewing in an oncology setting on the pharmacovigilance reporting in a comprehensive cancer centre

4CPS-194 The underreporting rate as a pharmacovigilance process indicator in a comprehensive cancer centre

4CPS-233 Coverage of energy and protein needs in patients with kidney failure or liver failure receiving total parenteral nutrition

3PC-044 In use physicochemical stability of pembrolizumab under the dilution condition required for use in a day hospital

5PSQ-049 Palbociclib in metastatic breast cancer treatment: real life toxicity and frequency of dose reduction or permanent discontinuation

GM-021 Zoledronic acid versus denosumab: a budget impact analysis

CP-082 Impact of pharmacists’ expertise on personalised parenteral nutrition prescriptions in an intensive care unit: physicians’ perceptions

5PSQ-117 Failure mode and effects criticality analysis: multicentric application on cancer chemotherapy process

4CPS-231 The use of cannabis oil in oncological pain: analysis of the outcomes in real practice at a cancer centre

GM-019 Analysis of the categories of clinical trials in an oncological institute: glimpse into the future

Thalidomide in patients with advanced hepatocellular carcinoma: A clinical/biological study

Tie2 Expressing Monocytes in the Spleen of Patients with Primary Myelofibrosis

Tumor cell proliferation in early gastric cancer: biological and clinical behavior

The role of surgery in the multimodal treatment of primary gastric non‐Hodgkin's lymphomas a report of 76 cases and review of the literature

Catheter seeding of hepatocellular carcinoma following placement of a total implantable access port system

Correlation of cell proliferation and clinical behaviour of early gastric cancer. Immunohistochemical study with "in vivo" bromodeoxyuridine labelling

Protein-sparing therapy after major abdominal surgery : Lack of clinical effects

Depression among general hospital patients in Greece

Pre-operative nutritional support and tumour cell kinetics in malnourished patients with gastric cancer

FEC vs high dose fec in the treatment of advanced breast cancer

The role of surgery in the multimodal treatment of primary gastric non-hodgkin's lymphomas

P.21 Modifications of immunological parameters during pre and postoperative tpn with and without fat emulsions in gastric cancer patients

Suchergebnisse filtern